Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?

被引：1
|
作者：
Samson, M. [1 ,2 ,3 ]
Bonnotte, B. [1 ,2 ,3 ]
机构：
[1] CHU Dijon Bourgogne, Serv Med Interne, 2 Blvd Mal de Lattre de Tassigny, F-21000 Dijon, France
[2] CHU Dijon Bourgogne, Immunol Clin, 2 Blvd Mal de Lattre de Tassigny, F-21000 Dijon, France
[3] Univ Bourgogne Franche Comte, FHU Increase, Inserm U1098, F-21000 Dijon, France
来源：
REVUE DE MEDECINE INTERNE | 2018年 / 39卷 / 02期
关键词：
Giant cell arteritis; Treatment; Tocilizumab; LARGE-VESSEL VASCULITIS; TAKAYASU ARTERITIS; DOUBLE-BLIND; THERAPY; TRIAL; ABATACEPT;
D O I：
10.1016/j.revmed.2017.11.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：75 / 77
页数：3
相关论文
共 50 条
  • [31] Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study
    Muratore, Francesco
    Marvisi, Chiara
    Cassone, Giulia
    Ricordi, Caterina
    Boiardi, Luigi
    Mancuso, Pamela
    Besutti, Giulia
    Spaggiari, Lucia
    Casali, Massimiliano
    Croci, Stefania
    Durmo, Rexhep
    Versari, Annibale
    Di Tommaso, Gabriella
    Catanoso, Mariagrazia
    Giorgi Rossi, Paolo
    Salvarani, Carlo
    RHEUMATOLOGY, 2024,
  • [32] Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritis
    Reichenbach, Stephan
    Adler, Sabine
    Bonel, Harald
    Cullmann, Jennifer L.
    Kuchen, Stefan
    Butikofer, Lukas
    Seitz, Michael
    Villiger, Peter M.
    RHEUMATOLOGY, 2018, 57 (06) : 982 - 986
  • [33] Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis
    Matteson, Eric L.
    Buttgereit, Frank
    Dejaco, Christian
    Dasgupta, Bhaskar
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (01) : 75 - +
  • [34] Magnetic resonance imaging to monitor disease activity in giant cell arteritis treated with ultra-short glucocorticoids and tocilizumab
    Christ, Lisa
    Bonel, Harald M.
    Cullmann, Jennifer L.
    Seitz, Luca
    Butikofer, Lukas
    Wagner, Franca
    Villiger, Peter M.
    RHEUMATOLOGY, 2024,
  • [35] Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study
    Samson, Maxime
    Devilliers, Herve
    Ly, Kim Heang
    Maurier, Francois
    Bienvenu, Boris
    Terrier, Benjamin
    Charles, Pierre
    Guillevin, Loic
    Besancenot, Jean-Francois
    Liozon, Eric
    Fauchais, Anne Laure
    Loffroy, Romaric
    Binquet, Christine
    Audia, Sylvain
    Seror, Raphaele
    Mariette, Xavier
    Bonnotte, Bernard
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 57 : 96 - 104
  • [36] Comment on: Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study
    Khan, Sheharyar Hassan
    RHEUMATOLOGY, 2024, 63 (12) : e345 - e345
  • [37] Giant cell arteritis with ocular involvement successfully treated with tocilizumab and very short-course glucocorticoids: A case report
    Khanna, R. K.
    Hage, R.
    Lecler, A.
    Sene, T.
    Vignal-Clermont, C.
    Clavel-Refregiers, G.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2021, 44 (04): : 481 - 484
  • [38] Tocilizumab for Giant Cell Arteritis-A New Giant Step in an Old Disease
    Tamaki, Hiromichi
    Hajj-Ali, Rula A.
    JAMA NEUROLOGY, 2018, 75 (02) : 145 - 146
  • [39] PREDICTIVE FACTORS OF RELAPSE IN GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB
    Herrero-Morant, A.
    Loricera, J.
    Ferraz-Amaro, I.
    Castaneda, S.
    Moriano, C.
    Narvaez, J.
    Aldasoro, V.
    Maiz, O.
    Melero, R.
    Villa-Blanco, I.
    Vela-Casasempere, P.
    Romero-Yuste, S.
    Callejas-Rubio, J. L.
    De Miguel, E.
    Galindez-Agirregoikoa, E.
    Sivera, F.
    Fernandez-Lopez, C.
    Galisteo, C.
    Sanchez-Martin, J.
    Calderon-Goercke, M.
    Sanchez-Bilbao, L.
    Hernandez, J. L.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1557 - 1558
  • [40] BASELINE DATA ON PATIENTS IN GIACTA (TOCILIZUMAB IN GIANT CELL ARTERITIS)
    Tuckwell, K.
    Collinson, N.
    Klearman, M.
    Dimonaco, S.
    Stone, J. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 514 - 514
12345